Search for: "United States v. AT&T, Inc." Results 8421 - 8440 of 8,840
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Jan 2008, 8:33 pm
Mark Anderson of The Wall Street Journal reports today that the United Supreme Court has agreed to hear an appeal of a decision by the United States Court of Appeals for the Fifth Circuit in a class action by Enron investors against numerous Wall Street firms, "striking a fatal blow against the class-action investor lawsuit. [read post]
18 Jan 2008, 2:34 pm
Abbott Laboratories, United States Court of Appeals for the Federal Circuit (07-1145). [read post]
17 Jan 2008, 10:00 pm
, (Chicago IP Litigation Blog), (more from Chicago IP Litigation Blog), (Washington State Patent Law Blog), (Harold Wegner), Global101 reasons for not selling your unused trade marks: (IPKat),ICANN to battle domain name tasting: (Trademark Blog), (related coverage from Trademark Blog),Is a patent a monopoly? [read post]
15 Jan 2008, 6:31 am
"We don't speak Canadian.And we sure as heck don't do Canadian law.But just when the United States seems to be coming to its senses about claims for medical monitoring, Canada slipped a gasket. [read post]
14 Jan 2008, 4:41 am
This morning, January 16th, the United States Supreme Court will hear oral arguments in the case of Mead Corp. v. [read post]
14 Jan 2008, 3:24 am
Attorney for the State: Joby Jerrells, Indianapolis, IN. 9:45 AM - Brenwick Associates, LLC v. [read post]
13 Jan 2008, 4:47 pm
Because statutes enacted under the Spending Clause of the United States Constitution must provide clear notice to the States of their liabilities should they decide to accept federal funding under those statutes, and because we conclude that NCLB fails to provide clear notice as to who bears the additional costs of compliance, we REVERSE the judgment of the district court and REMAND this case for further proceedings consistent with this opinion. 08a0007p.06 Blackburn… [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]